{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T08:43:34Z","timestamp":1782809014531,"version":"3.54.5"},"reference-count":30,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T00:00:00Z","timestamp":1087516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>To evaluate the effect of chemotherapy on humoral immunity to vaccine\u2010preventable disease, the authors investigated the persistence of protective antibody titers in a group of patients who were alive and well after they were treated for pediatric malignancies.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS<\/jats:title><jats:p>Serum antibody levels were evaluated for polio, tetanus, hepatitis B, rubella, mumps, and measles in 192 children. The terms <jats:italic>lack of immunity<\/jats:italic> and <jats:italic>loss of immunity<\/jats:italic>, respectively, were used to describe the absence of immunity in patients who were tested only after chemotherapy and in patients who were tested both before and after chemotherapy and determined to have immunity before chemotherapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>Overall, the absence of a protective serum antibody titer for hepatitis B, measles, mumps, rubella, tetanus, and polio was detected in 46%, 25%, 26%, 24%, 14%, and 7% of patients, respectively. On univariate analysis, loss of antibodies against rubella, mumps, and tetanus was associated significantly with younger age (<jats:italic>P<\/jats:italic> &lt; 0.001, <jats:italic>P<\/jats:italic> = 0.02, and <jats:italic>P<\/jats:italic> = 0.001, respectively), and loss of antibodies against measles was significantly associated with younger age and female gender (<jats:italic>P<\/jats:italic> = 0.0003 and <jats:italic>P<\/jats:italic> = 0.008, respectively). The administration of 59 booster vaccinations to 51 patients who had lost \u2265 1 protective antibody titer resulted in an overall response rate of 93%.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>Chemotherapy induced different rates of loss of protective antibody titers depending on the type of vaccination administered. This finding may be responsible for the failure of vaccination programs for patients who have undergone chemotherapy. The administration of a booster dose after the completion of chemotherapy is a simple and cost\u2010effective way to restore humoral immunity against most vaccine\u2010preventable diseases. Cancer 2004. \u00a9 2004 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.20384","type":"journal-article","created":{"date-parts":[[2004,6,18]],"date-time":"2004-06-18T18:00:51Z","timestamp":1087581651000},"page":"635-641","source":"Crossref","is-referenced-by-count":138,"title":["Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy"],"prefix":"10.1002","volume":"101","author":[{"given":"Matteo","family":"Zignol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Peracchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Tridello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Pillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Fregonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruggiero","family":"D'Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Zanesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,6,18]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"241","article-title":"Ten great public health achievements\u2014United States, 1900\u20131999","volume":"48","author":"Centers for Disease Control and Prevention","year":"1999","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_3_2","first-page":"1","article-title":"Summary of notifiable diseases\u2014United States, 2000","volume":"49","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_4_2","first-page":"31","article-title":"Recommended childhood immunization schedule\u2014United States, 2002","volume":"51","author":"Centers for Disease Control and Prevention","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_5_2","first-page":"1174","volume-title":"Nelson textbook of pediatrics","author":"Peter G","year":"2003"},{"key":"e_1_2_6_6_2","first-page":"1","volume-title":"Principles and practice of pediatric oncology","author":"Smith MA","year":"2002"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19920315)69:6<1481::AID-CNCR2820690628>3.0.CO;2-L"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/08880019409141671"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-199809000-00008"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400970"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.8.2370"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.2.496"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V84.2.657.657","article-title":"Long term immunity to measles, rubella and mumps in patients after allogeneic bone marrow transplantation","volume":"84","author":"Ljungman P","year":"1994","journal-title":"Blood"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701289"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701641"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701640"},{"key":"e_1_2_6_17_2","first-page":"445","article-title":"Immunizations after bone marrow transplantation: results of a European survey and recommendations from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"15","author":"Ljungman P","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/bbmt.2001.v7.pm11302551"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.109.6.e91"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050196"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1542\/peds.67.2.222","article-title":"Immunity to diphtheria, pertussis, tetanus and poliomyelitis in children with acute lymphoblastic leukemia after cessation of therapy","volume":"67","author":"Van den Does\u2010Van der Berg A","year":"1981","journal-title":"Pediatrics"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1086\/514661"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401963"},{"key":"e_1_2_6_24_2","first-page":"791","article-title":"Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP\u2010ALL91 study","volume":"83","author":"Conter V","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.6.1046"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.05.191"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11285"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<97::AID-MPO4>3.0.CO;2-8"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930915)72:6<2049::AID-CNCR2820720642>3.0.CO;2-V"},{"key":"e_1_2_6_30_2","first-page":"58","article-title":"Analysis of the AIEOP LNH\u201092 protocol for the diagnosis and treatment of pediatric non\u2010B cell non\u2010Hodgkin's lymphomas","volume":"25","author":"Rosolen R","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"e_1_2_6_31_2","first-page":"58","article-title":"Results of the AIEOP NHL\u201092 protocol for the treatment of pediatric anaplastic large cell lymphomas","volume":"25","author":"Pillon M","year":"2003","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.20384","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.20384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T09:11:04Z","timestamp":1760260264000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.20384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,18]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1002\/cncr.20384"],"URL":"https:\/\/doi.org\/10.1002\/cncr.20384","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,18]]}}}